As Nanjing’s first IP operation center approved by the national authority, it has already:

Served over 500 enterprises
Enabled ¥1.1 trillion in patent industrialization
Formed an IP alliance of 43 institutions including universities and financial organizations
Facilitated 600+ patent transfers and licenses

Nanjing is setting a new benchmark for innovation-driven growth in the biopharmaceutical sector.